-
1
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
-
(2002)
Am J Kidney Dis
, vol.39
-
-
-
2
-
-
13844283602
-
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population
-
PREVEND Study Group
-
Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE; PREVEND Study Group. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl. 2004;92:S18-S21.
-
(2004)
Kidney Int Suppl
, vol.92
-
-
Verhave, J.C.1
Gansevoort, R.T.2
Hillege, H.L.3
Bakker, S.J.4
De Zeeuw, D.5
de Jong, P.E.6
-
3
-
-
0036788492
-
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population
-
Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group
-
Hillege HL, Fidler V, Diercks GF, et al; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777-1782.
-
(2002)
Circulation
, vol.106
, pp. 1777-1782
-
-
Hillege, H.L.1
Fidler, V.2
Diercks, G.F.3
-
4
-
-
0034082720
-
Arterial hypertension, microalbuminuria, and risk of ischemic heart disease
-
Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35:898-903.
-
(2000)
Hypertension
, vol.35
, pp. 898-903
-
-
Jensen, J.S.1
Feldt-Rasmussen, B.2
Strandgaard, S.3
Schroll, M.4
Borch-Johnsen, K.5
-
5
-
-
33847711876
-
Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients
-
Halimi JM, Buchler M, Al-Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant. 2007;7:618-625.
-
(2007)
Am J Transplant
, vol.7
, pp. 618-625
-
-
Halimi, J.M.1
Buchler, M.2
Al-Najjar, A.3
-
6
-
-
23844491509
-
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study
-
Arnlöv J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969-975.
-
(2005)
Circulation
, vol.112
, pp. 969-975
-
-
Arnlöv, J.1
Evans, J.C.2
Meigs, J.B.3
-
7
-
-
0035948631
-
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
-
HOPE Study Investigators
-
Gerstein HC, Mann JF, Yi Q, et al; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-426.
-
(2001)
JAMA
, vol.286
, pp. 421-426
-
-
Gerstein, H.C.1
Mann, J.F.2
Yi, Q.3
-
8
-
-
0034005754
-
Long-term survival in renal transplant recipients with graft function
-
Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000;57:307-313.
-
(2000)
Kidney Int
, vol.57
, pp. 307-313
-
-
Ojo, A.O.1
Hanson, J.A.2
Wolfe, R.A.3
Leichtman, A.B.4
Agodoa, L.Y.5
Port, F.K.6
-
9
-
-
8144224441
-
Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
-
Asselbergs FW, Diercks GF, Hillege HL, et al. Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004;110:2809-2816.
-
(2004)
Circulation
, vol.110
, pp. 2809-2816
-
-
Asselbergs, F.W.1
Diercks, G.F.2
Hillege, H.L.3
-
10
-
-
4344621497
-
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
-
de Zeeuw D, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110:921-927.
-
(2004)
Circulation
, vol.110
, pp. 921-927
-
-
de Zeeuw, D.1
Remuzzi, G.2
Parving, H.H.3
-
11
-
-
19944432108
-
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study
-
Ibsen H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45:198-202.
-
(2005)
Hypertension
, vol.45
, pp. 198-202
-
-
Ibsen, H.1
Olsen, M.H.2
Wachtell, K.3
-
12
-
-
2142805166
-
Renoprotective effects of losartan in renal transplant recipients: Results of a retrospective study
-
Iñigo P, Campistol JM, Saracho R, et al. Renoprotective effects of losartan in renal transplant recipients: results of a retrospective study. Nephron Clin Pract. 2003;95:c84-c90.
-
(2003)
Nephron Clin Pract
, vol.95
-
-
Iñigo, P.1
Campistol, J.M.2
Saracho, R.3
-
13
-
-
0242300606
-
Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction
-
Omoto K, Tanabe K, Tokumoto T, Shimmura H, Ishida H, Toma H. Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction. Transplantation. 2003;76:1170-1174.
-
(2003)
Transplantation
, vol.76
, pp. 1170-1174
-
-
Omoto, K.1
Tanabe, K.2
Tokumoto, T.3
Shimmura, H.4
Ishida, H.5
Toma, H.6
-
14
-
-
0342636985
-
The Microalbuminuria Captopril Study Group
-
Captopril reduces the risk of nephropathy in I.D.D.M patients with microalbuminuria
-
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group. Diabetologia. 1996;39:587-593.
-
(1996)
Diabetologia
, vol.39
, pp. 587-593
-
-
-
15
-
-
65549111017
-
Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan
-
Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-992.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 982-992
-
-
Matsuo, S.1
Imai, E.2
Horio, M.3
-
16
-
-
77951731560
-
Transplant tolerance: Progress and challenges
-
Casiraghi F, Aiello S, Remuzzi G. Transplant tolerance: progress and challenges. J Nephrol. 2010;23:263-270.
-
(2010)
J Nephrol
, vol.23
, pp. 263-270
-
-
Casiraghi, F.1
Aiello, S.2
Remuzzi, G.3
-
17
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
18
-
-
0042330455
-
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
-
EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
-
Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-788.
-
(2003)
Lancet
, vol.362
, pp. 782-788
-
-
Fox, K.M.1
-
19
-
-
0037160969
-
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
LIFE Study Group
-
Lindholm LH, Ibsen H, Dahlöf B, et al; LIFE Study Group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:1004-1010.
-
(2002)
Lancet
, vol.359
, pp. 1004-1010
-
-
Lindholm, L.H.1
Ibsen, H.2
Dahlöf, B.3
-
20
-
-
79960290362
-
The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease
-
Mar 22 (in press)
-
Dounaevskaia V, Yan AT, Charytan D, et al. The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease. J Nephrol. 2010 Mar 22 (in press).
-
(2010)
J Nephrol
-
-
Dounaevskaia, V.1
Yan, A.T.2
Charytan, D.3
-
21
-
-
33645451066
-
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation
-
Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006;17:889-899.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 889-899
-
-
Heinze, G.1
Mitterbauer, C.2
Regele, H.3
-
22
-
-
0030886126
-
Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis
-
Klaassen RJ, van Gelder T, Rischen-Vos J, Deinum J. Man in't Veld AJ, Weimar W. Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis. Transplantation. 1997;64:780-782.
-
(1997)
Transplantation
, vol.64
, pp. 780-782
-
-
Klaassen, R.J.1
van Gelder, T.2
Rischen-Vos, J.3
Deinum, J.4
Manin't Veld, A.J.5
Weimar, W.6
|